Xi Li
- Molecular Biology top 10%
- Cancer Research top 2%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Pharmacology top 5%
- Topics
- Cancer-related molecular mechanisms research (12 papers)Pharmacogenetics and Drug Metabolism (9 papers)RNA modifications and cancer (8 papers)
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Xi Li
84 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 130
- Molecular Biology 1.0k
- Cancer Research 662
- Oncology 286
- Pulmonary and Respiratory Medicine 226
- Pharmacology 133
Countries citing papers authored by Xi Li
This map shows the geographic impact of Xi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Li more than expected).
Fields of papers citing papers by Xi Li
This network shows the impact of papers produced by Xi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Li. The network helps show where Xi Li may publish in the future.
Co-authorship network of co-authors of Xi Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xi Li. A scholar is included among the top collaborators of Xi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Li. Xi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 8 | |
| 9 | 6 | |
| 10 | 14 | |
| 11 | 8 | |
| 12 | 48 | |
| 13 | 34 | |
| 14 | 61 | |
| 15 | 61 | |
| 16 | 25 | |
| 17 | 73 | |
| 18 | 150 | |
| 19 | 22 | |
| 20 | Stage-specific Expression Analysis of Mouse Testis-specific Genes in Spermatogenic Cells | 1 |
About Xi Li
Xi Li is a scholar working on Cancer Research, Pharmacology and Nutrition and Dietetics, having authored 92 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), Pharmacogenetics and Drug Metabolism (9 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Cancer Research (662 citations), Pharmacology (133 citations) and Molecular Biology (1.0k citations). Xi Li has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Zhaoqian Liu, Ji‐Ye Yin, Wei Zhang, Hong‐Hao Zhou, Hong‐Hao Zhou, Xiao‐Yuan Mao, Hong‐Hao Zhou, Rong Liu, Di Xiao and Zhibin Wang. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.